Laxai Inc. has received a growth capital investment from Signet Healthcare Partners, a New York-based healthcare private equity firm. The equity investment aims to provide Laxai with a long-term, well-capitalized financial partner that will support Laxai’s growth strategy.   Laxai, including its subsidiaries, is an Integrated Contract Research, Development, and Manufacturing Organization (CRDMO) that delivers solutions in drug discovery, chemical process R&D, and GMP manufacturing for inno...